TNF and rheumatoid arthritis: Liao et al. (2016) demonstrated that, among patients with rheumatoid arthritis, chronic kidney disease and exposure to the monoclonal anti-TNF antibody adalimumab were significantly associated with an increased risk of cryptococcal infection [4].